Recursion Pharmaceuticals-a (RXRX) 13F Holders & Ownership Data (348 Funds, Q2 2026)

RXRX ranks #1799 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

RXRX is a disclosed holding of Cathie Wood (ARK Investment Management), one of the tracked superinvestors on AlphaSMO — it makes up 1.0% of that fund's own 13F portfolio.

RXRX is a top-conviction position for DCVC Opportunity Fund II GP, LLC — at 84.3% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in RXRX belongs to California State Teachers Retirement System, but the position matters far more to DCVC Opportunity Fund II GP, LLC, who has 84.3% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

California State Teachers Retirement System has added to its RXRX position for two straight quarters, increasing it by $558.8M to reach $560.2M today.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC has trimmed its RXRX position for two straight quarters, cutting it by $13.9M while still holding $2.8M.

RXRX is down 2.9% today, but institutions show net buying of $203.2M this quarter — a divergence between today's price move and the underlying institutional flow.

RXRX reported a net loss of $518.9M over the trailing twelve months.

• Not yet profitable — net loss of $518.9M over the trailing twelve months
• Revenue declined 15.1% year over year
• Net income improved year over year, from -$649.1M to -$518.9M
• Operating cash flow was negative, using $371.8M in cash
• Current ratio of 5.50x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.30x equity — within a conventional range